Stock CLS CLICKS GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Clicks Group Limited

Equities

CLS

ZAE000134854

Drug Retailers

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
285.6 ZAR -0.10% Intraday chart for Clicks Group Limited +0.54% -12.31%
Apr. 25 Clicks Group Limited Reports Earnings Results for the Half Year Ended February 29, 2024 CI
Apr. 25 Transcript : Clicks Group Limited, H1 2024 Earnings Call, Apr 25, 2024

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 50,275 57,192 74,296 72,708 66,179 67,991 - -
Enterprise Value (EV) 1 47,662 55,040 72,089 70,693 63,724 65,795 65,443 64,965
P/E ratio 29.6 x 30.6 x 40.7 x 28.9 x 26.2 x 24.2 x 21.8 x 19.6 x
Yield 2.24% 1.96% 1.62% 2.14% 2.48% 2.67% 2.99% 3.33%
Capitalization / Revenue 1.6 x 1.66 x 1.99 x 1.84 x 1.59 x 1.5 x 1.37 x 1.26 x
EV / Revenue 1.52 x 1.6 x 1.93 x 1.79 x 1.53 x 1.45 x 1.32 x 1.2 x
EV / EBITDA 17.7 x 14.1 x 17.3 x 14.2 x 12.4 x 11.6 x 10.4 x 9.36 x
EV / FCF - 59.4 x 44.4 x 65.5 x 26.8 x 18.7 x 15.9 x 12.8 x
FCF Yield - 1.68% 2.25% 1.53% 3.73% 5.36% 6.28% 7.83%
Price to Book 10.2 x 11 x 15.5 x 12.8 x 11.1 x 11.1 x 10 x 8.97 x
Nbr of stocks (in thousands) 252,640 248,663 245,557 243,970 241,971 238,062 - -
Reference price 2 199.0 230.0 302.6 298.0 273.5 285.6 285.6 285.6
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 31,352 34,364 37,339 39,587 41,622 45,372 49,579 53,988
EBITDA 1 2,692 3,898 4,157 4,971 5,142 5,687 6,309 6,944
EBIT 1 2,321 2,767 2,897 3,325 3,623 4,088 4,559 5,037
Operating Margin 7.4% 8.05% 7.76% 8.4% 8.7% 9.01% 9.2% 9.33%
Earnings before Tax (EBT) 1 2,364 2,584 2,642 3,639 3,471 3,897 4,300 4,749
Net income 1 1,703 1,880 1,838 2,523 2,538 2,835 3,145 3,492
Net margin 5.43% 5.47% 4.92% 6.37% 6.1% 6.25% 6.34% 6.47%
EPS 2 6.718 7.514 7.438 10.33 10.42 11.81 13.13 14.59
Free Cash Flow 1 - 925.9 1,622 1,079 2,380 3,527 4,107 5,087
FCF margin - 2.69% 4.34% 2.73% 5.72% 7.77% 8.28% 9.42%
FCF Conversion (EBITDA) - 23.75% 39.02% 21.71% 46.29% 62.01% 65.09% 73.26%
FCF Conversion (Net income) - 49.25% 88.25% 42.79% 93.79% 124.4% 130.57% 145.67%
Dividend per Share 2 4.450 4.500 4.900 6.370 6.790 7.639 8.535 9.516
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2
Net sales 1 16,857 17,508 18,134 19,205 - 20,030
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income - - - - 1,206 -
Net margin - - - - - -
EPS 2 3.380 4.134 3.589 3.849 4.928 5.399
Dividend per Share - - - - - -
Announcement Date 4/23/20 10/22/20 4/23/21 10/27/21 4/28/22 10/20/22
1ZAR in Million2ZAR
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,614 2,152 2,207 2,015 2,455 2,196 2,548 3,025
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - 926 1,622 1,079 2,380 3,527 4,107 5,087
ROE (net income / shareholders' equity) 36.5% 37.7% 38.2% 48% 43.6% 46.3% 46.1% 45.8%
ROA (Net income/ Total Assets) 13.8% 12.4% - - 13.8% 14.5% 14.8% 15%
Assets 1 12,322 15,172 - - 18,388 19,587 21,197 23,206
Book Value Per Share 2 19.50 20.90 19.60 23.40 24.70 25.70 28.50 31.80
Cash Flow per Share 2 7.440 6.060 9.360 7.850 13.60 15.20 17.30 19.10
Capex 1 647 591 690 838 930 889 883 889
Capex / Sales 2.06% 1.72% 1.85% 2.12% 2.23% 1.96% 1.78% 1.65%
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Clicks Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
285.6 ZAR
Average target price
307.8 ZAR
Spread / Average Target
+7.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-6.93% 3.01B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. CLS Stock
  4. Financials Clicks Group Limited